previous compound ID: 2034 next compound
InChIKey: RXKMOPXNWTYEHI-RDRKJGRWSA-N
SMILES: C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F.Cl.Cl

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"R Robert" "GW Carlile" "JW Hanrahan" "E Matthes" "D Rotin" "B Kus" "J Goepp" "DY Thomas" "SD Macknight" "J Liao"

chemical graph of compound 2034





CID is 5282407
synonyms found at PubChem are:
Flunarizine dihydrochloride, 30484-77-6, flunarizine hydrochloride, Flunarizine 2HCl, Flunarizine HCl, Flunarizine diHCl, Flunarizine (dihydrochloride), UNII-C11102TO53, EINECS 250-216-6, Flunarizine hydrochloride [USAN:JAN], 1-(Bis(4-fluorophenyl)methyl)-4-cinnamylpiperazine dihydrochloride, KW-3149, R 14950, C11102TO53, (E)-1-(Bis-(p-fluorophenyl)methyl)-4-cinnamylpiperazine dihydrochloride, 1-[Bis(4-fluorophenyl)methyl]-4-(3-phenyl-2-propenyl)piperazine dihydrochloride, (E)-1-(Bis(4-fluorophenyl)methyl)-4-(3-phenyl-2-propenyl)piperazine dihydrochloride, R-14950, (E)-1-(Bis(4-fluorophenyl)methyl)-4-cinnamylpiperazine dihydrochloride, Piperazine, 1-(bis(p-fluorophenyl)methyl)-4-cinnamyl-, dihydrochloride, (E)-, 1-[bis(4-fluorophenyl)methyl]-4-[(E)-3-phenylprop-2-enyl]piperazine dihydrochloride, Piperazine, 1-(bis(4-fluorophenyl)methyl)-4-(3-phenyl-2-propenyl)-, dihydrochloride, (E)-, SR-01000000006, 27064-95-5, Flugeral, (E)-1-[Bis(4-fluorophenyl)methyl]-4-(3-phenyl-2-propenyl)piperazine dihydrochloride, 1-[bis(4-fluorophenyl)methyl]-4-[(E)-3-phenylprop-2-enyl]piperazine;dihydrochloride, Prestwick_222, EINECS 248-203-5, AC1NR00J, Flunarizine hydrochloride,(S), SPECTRUM1500993, C26H26F2N2.2HCl, C26H28Cl2F2N2, CHEMBL552659, SCHEMBL1009444, SCHEMBL1321708, CHEBI:31621, HY-B0358A, DTXSID80184554, 1-[bis (4-fluorophenyl)methyl]-4-(3-phenyl-2-propenyl)-piperazine dihydrochloride, MolPort-000-825-358, HMS1568P06, HMS1921O12, 52468-60-7 (Parent), BCP02932, Tox21_500527, CCG-39000, MFCD00058198, s2030, Flunarizine hydrochloride (JAN/USAN), AKOS015895373, AC-2152, BCP9000695, CS-2412, KS-5125, LP00527, NCGC00093920-01, NCGC00093920-02, NCGC00093920-03, NCGC00261212-01, AN-14275, BC201114, KB-51879, BCP0726000286, AB0012900, AB1009511, Flunarizine dihydrochloride, >=98% (TLC), LS-110458, EU-0100527, ST24047212, ST51015006, D01303, F 8257, K-7304, 484F776, A820398, C-22772, I06-0614, Q-100983, R 14,950, SR-01000000006-2, SR-01000000006-4, SR-01000000006-9, Flunarizine Dihydrochloride 1.0 mg/ml in Methanol (as free base), 1-[bis(4-fluorophenyl)methyl]-4-[(E)-cinnamyl]piperazine dihydrochloride, Flunarizine dihydrochloride, European Pharmacopoeia (EP) Reference Standard, 1-[bis(4-fluorophenyl)methyl]-4-(3-phenyl-2-propenyl)-piperazine dihydrochloride, 1-[bis(4-fluorophenyl)methyl]-4-(3-phenylprop-2-en-1-yl)piperazine dihydrochloride, 4-((2E)-3-phenylprop-2-enyl)-1-[bis(4-fluorophenyl)methyl]piperazine, chloride , chloride, Flunarizine dihydrochloride for system suitability, European Pharmacopoeia (EP) Reference Standard, AKOS026749953